The state of CDKN2A genetic and epigenetic alterations has been reported in several forms of human tumors [48,49]; therefore it is important to define the different shapes of these alterations, investigate their consequences on tumor progression and patient survival, and study the modifications that occur to the immune system components as a result of those alterations. The gene discussed is CDKN2A; the disease is neoplasm.